Matinas BioPharma Holdings, Inc. logo

Matinas BioPharma Holdings, Inc.

AMEX:MTNB

Overview | Financials
Company Name Matinas BioPharma Holdings, Inc.
Symbol MTNB
Currency USD
Price 0.235
Market Cap 50,970,367
Dividend Yield 0%
52-week-range 0.11 - 0.89
Industry Biotechnology
Sector Healthcare
CEO Mr. Jerome D. Jabbour J.D.
Website https://www.matinasbiopharma.com

An error occurred while fetching data.

About Matinas BioPharma Holdings, Inc.

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and

Related Stocks

Armata Pharmaceuticals, Inc. logo

Armata Pharmaceuticals, Inc.

ARMP

2.22 USD

VolitionRx Limited logo

VolitionRx Limited

VNRX

0.748 USD

Stereotaxis, Inc. logo

Stereotaxis, Inc.

STXS

1.56 USD

CEL-SCI Corporation logo

CEL-SCI Corporation

CVM

2.18 USD

Retractable Technologies, Inc. logo

Retractable Technologies, Inc.

RVP

1.08 USD

Actinium Pharmaceuticals, Inc. logo

Actinium Pharmaceuticals, Inc.

ATNM

4.49 USD

InfuSystem Holdings, Inc. logo

InfuSystem Holdings, Inc.

INFU

9.29 USD

Cybin Inc. logo

Cybin Inc.

CYBN

0.45 USD

Electromed, Inc. logo

Electromed, Inc.

ELMD

10.5 USD

Lineage Cell Therapeutics, Inc. logo

Lineage Cell Therapeutics, Inc.

LCTX

0.95 USD

Financials

Numbers are in millions USD

Numbers are in millions USD